GSK Studentships
Global biopharma company GSK is investing up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring the potential of cancer prevention through vaccination.
The programme leverages the complementary expertise of GSK and Oxford in the science of the immune system, vaccine development and cancer biology. It is hoped that the insights generated through the programme into how cancer develops could inform new approaches to vaccination for cancer prevention, offering fresh hope in the fight against the disease.
We have two studentships available for the 2026 intake.
How to apply:
Applicants must apply with a prioritised list of three projects selected from the GSK booklet by midday on Thursday 8th January 2026.
Apply through the University of Oxford Graduate Admissions website for the relevant track.
On the application form, in the section headed ‘Departmental Studentship Applications’, you must indicate that you are applying for the GSK studentship and enter the reference code for this studentship “GSK25”
Please note, GSK funded students are part of the wider Cancer Science DPhil programme. You’ll attend the same seminars, training sessions, and events, and be part of the same research community as all other Cancer Science students. The only difference is how your project is funded.